News

All Releases
Abbott and Tandem Diabetes Care Exploring New Integrated Solutions to Improve Diabetes Management
Oct 15, 2019
- Companies aim to integrate Abbott's FreeStyle Libre glucose sensing technology with Tandem's insulin delivery products to expand choices for people with diabetes ABBOTT PARK, Ill. and SAN DIEGO , Oct. 15, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) and Tandem Diabetes Care (NASDAQ: TNDM) announced
Tandem Diabetes Care to Announce Third Quarter 2019 Financial Results on November 4, 2019
Oct 14, 2019
SAN DIEGO --(BUSINESS WIRE)--Oct. 14, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2019 results after the financial markets close on Monday, November 4, 2019 .
Tandem Diabetes Care Announces Publication of Real-world Basal-IQ Predictive Low Glucose Suspend Technology Data in Diabetes Technology and Therapeutics Journal
Sep 18, 2019
SAN DIEGO --(BUSINESS WIRE)--Sep. 18, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced publication of real-world data from more than 8,000 users of the t:slim X2™ insulin pump with Basal-IQ® predictive low-glucose suspend
Tandem Diabetes Care Announces Upcoming Conference Participation and Presentations
Aug 29, 2019
SAN DIEGO --(BUSINESS WIRE)--Aug. 29, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will be attending the following upcoming investor conferences: Baird Global Healthcare Conference on Wednesday,
Tandem Diabetes Care Announces Second Quarter 2019 Financial Results and Updated 2019 Financial Guidance
Aug 01, 2019
SAN DIEGO --(BUSINESS WIRE)--Aug. 1, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2019 and updated its financial guidance for the year ending December 31, 2019 .
Tandem Diabetes Care Announces No-Cost Software Updates for t:slim X2 Insulin Pump Customers in the United States
Aug 01, 2019
SAN DIEGO --(BUSINESS WIRE)--Aug. 1, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced it is offering no-cost feature updates for t:slim X2 insulin pump customers in the United States through the end of 2020.
Tandem Diabetes Care to Announce Second Quarter 2019 Financial Results on August 1, 2019
Jul 19, 2019
SAN DIEGO --(BUSINESS WIRE)--Jul. 19, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2019 results after the financial markets close on Thursday, August 1, 2019 .
Tandem Diabetes Care Announces Upcoming Conference Presentation
Jun 20, 2019
SAN DIEGO --(BUSINESS WIRE)--Jun. 20, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that John Sheridan , president and chief executive officer, will present at the BMO 2019 Prescriptions for Success Healthcare
CORRECTING and REPLACING Tandem Diabetes Care Reports Positive Results From Two Studies of the t:slim X2 Insulin Pump With Control-IQ Technology
Jun 13, 2019
Significant Time-in-Range Improvements Demonstrated in Adult and Pediatric Age Groups SAN FRANCISCO --(BUSINESS WIRE)--Jun. 13, 2019-- Fourth paragraph, fourth sentence of release dated June 9, 2019 , should read: Time spent below 70 mg/dL was 1.4 percent with Control-IQ technology compared to 1.9
Tandem Diabetes Care Reports Positive Results From Two Studies of the t:slim X2 Insulin Pump With Control-IQ Technology
Jun 09, 2019
Significant Time-in-Range Improvements Demonstrated in Adult and Pediatric Age Groups SAN FRANCISCO --(BUSINESS WIRE)--Jun. 9, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced positive results from two studies of the
Tandem Diabetes Care Announces Conference Call Following Data Presentations at the ADA Scientific Sessions
Jun 07, 2019
SAN DIEGO --(BUSINESS WIRE)--Jun. 7, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will hold a conference call on Sunday, June 9, 2019 at 8:00pm Eastern Time ( 5:00pm Pacific Time ) following data
Tandem Diabetes Care Announces Upcoming Conference Presentations
May 13, 2019
SAN DIEGO --(BUSINESS WIRE)--May 13, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a Company update at the following upcoming investor conferences: Bank of America Merrill Lynch Healthcare
Tandem Diabetes Care Announces First Quarter 2019 Financial Results and Updated 2019 Financial Guidance
Apr 30, 2019
SAN DIEGO --(BUSINESS WIRE)--Apr. 30, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2019 and updated its financial guidance for the year ending December 31, 2019 .
Tandem Diabetes Care to Announce First Quarter 2019 Financial Results on April 30, 2019
Apr 16, 2019
SAN DIEGO --(BUSINESS WIRE)--Apr. 16, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2019 results after the financial markets close on Tuesday, April 30, 2019 .
Tandem Diabetes Care Approved as Insulin Pump Vendor for ADP in Ontario, Canada
Mar 07, 2019
SAN DIEGO --(BUSINESS WIRE)--Mar. 7, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that it is now registered as an approved vendor of insulin pumps and supplies under the Assistive Devices Program (ADP) in Ontario,
Tandem Diabetes Care Announces Upcoming Conference Presentations
Mar 06, 2019
SAN DIEGO --(BUSINESS WIRE)--Mar. 6, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that John Sheridan , president and chief executive officer, will present at the following upcoming investor conferences: Cowen 39 th
Tandem Diabetes Care Announces Plan to Use Remote Software Update Tool in Ongoing Clinical Trial
Mar 06, 2019
SAN DIEGO --(BUSINESS WIRE)--Mar. 6, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that it intends to use its remote software update tool, the Tandem Device Updater, to resolve a Control-IQ technology software anomaly
Tandem Diabetes Care Announces Succession Plan for Chief Executive Officer and Board of Directors
Feb 26, 2019
SAN DIEGO --(BUSINESS WIRE)--Feb. 26, 2019-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced a succession plan for its chief executive officer (CEO) and select members of its board of directors.
Tandem Diabetes Care Reports 2018 Financial Results and 2019 Financial Guidance
Feb 26, 2019
SAN DIEGO --(BUSINESS WIRE)--Feb. 26, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter and year ended December 31, 2018 and financial guidance for the year ending December 31, 2019 .
Tandem Diabetes Care Appoints New Senior Vice President to Drive Expansion of Digital Health and Information Technology Initiatives
Feb 20, 2019
SAN DIEGO --(BUSINESS WIRE)--Feb. 20, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Manuel Jaime as its new Senior Vice President, Technology and Digital Health .
Displaying 1 - 20 of 193